Moilec (Meloxicam)

Meloxicam, the active ingredient in Moilec, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces pain and inflammation associated with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in adult patients.

GNH USA supplies Moilec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory‑approved batches to meet global demand.

Moilec (meloxicam) is indicated for inflammatory joint disorders and related pain conditions. - Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: reduces synovial inflammation and joint swelling. - Ankylosing spondylitis: diminishes spinal stiffness and pain. - General pain: provides analgesia for moderate musculoskeletal discomfort.

Meloxicam may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort (indigestion, nausea). - Headache. - Dizziness. - Peripheral edema. - Elevated blood pressure. - Skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction. - Renal impairment or failure. - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Hepatic enzyme elevation. - Anaphylactic reactions.

When prescribing meloxicam, clinicians should consider several safety measures. - Renal function: assess baseline kidney status before initiation. - Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent cardiac events. - Gastrointestinal history: use cautiously in those with prior ulcer disease. - Concomitant NSAIDs: avoid combined use to reduce bleeding risk. - Pregnancy and lactation: reserve for situations where benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Meloxicam can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: elevated serum lithium concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - SSRIs or SNRIs: enhanced bleeding tendency. - Diuretics: risk of electrolyte imbalance and renal effects.